Target Price | JPY2,393.33 |
Price | JPY2,166.50 |
Potential |
10.47%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Seven & i 2026 .
The average Seven & i target price is JPY2,393.33.
This is
10.47%
register free of charge
JPY2,900.00
33.86%
register free of charge
JPY2,000.00
7.69%
register free of charge
|
|
A rating was issued by 14 analysts: 3 Analysts recommend Seven & i to buy, 11 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Seven & i stock has an average upside potential 2026 of
10.47%
register free of charge
|
Feb '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 11,972.76 | 10,676.42 |
4.37% | 10.83% | |
EBITDA Margin | 7.04% | 8.89% |
12.42% | 26.26% | |
Net Margin | 1.45% | 2.69% |
26.18% | 86.09% |
13 Analysts have issued a sales forecast Seven & i 2026 . The average Seven & i sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Seven & i EBITDA forecast 2026. The average Seven & i EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Seven & i Analysts have issued a net profit forecast 2026. The average Seven & i net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Feb '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 66.61 | 110.87 |
21.52% | 66.45% | |
P/E | 19.54 | |
EV/Sales | 0.79 |
5 Analysts have issued a Seven & i forecast for earnings per share. The average Seven & i EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.